|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-1-12
|
|
pubmed:abstractText |
Two recent meta-analyses have shown a survival advantage for the addition of concurrent chemotherapy to radiotherapy in the treatment of cervical cancer. However, there is insufficient information available on late toxicity and few data from UK practice. The aims of this study were to examine treatment outcomes (survival and toxicity) in patients with cervical cancer treated with chemoradiation and to compare these with outcomes in patients treated with radiation alone.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0936-6555
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
49-55
|
|
pubmed:meshHeading |
pubmed-meshheading:19081712-Adult,
pubmed-meshheading:19081712-Aged,
pubmed-meshheading:19081712-Antineoplastic Agents,
pubmed-meshheading:19081712-Carcinoma,
pubmed-meshheading:19081712-Cisplatin,
pubmed-meshheading:19081712-Combined Modality Therapy,
pubmed-meshheading:19081712-Disease Progression,
pubmed-meshheading:19081712-Disease-Free Survival,
pubmed-meshheading:19081712-Female,
pubmed-meshheading:19081712-Humans,
pubmed-meshheading:19081712-Middle Aged,
pubmed-meshheading:19081712-Neoadjuvant Therapy,
pubmed-meshheading:19081712-Survival Rate,
pubmed-meshheading:19081712-Uterine Cervical Neoplasms,
pubmed-meshheading:19081712-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Clinical outcome for chemoradiotherapy in carcinoma of the cervix.
|
|
pubmed:affiliation |
Department of Clinical Oncology, Christie Hospital, Manchester, UK. saiqa.spensley@slh.ie
|
|
pubmed:publicationType |
Journal Article
|
